FAM182B: A Potential Drug Target Or Biomarker (G728882)

Target Name: FAM182B

NCBI ID: G728882

FAM182B

Other Name(s): FAM182B variant 1 | family with sequence similarity 182 member B | Family with sequence similarity 182 member B, transcript variant 1

FAM182B: A Potential Drug Target Or Biomarker

FAM182B (FAM182B variant 1) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The FAM182B gene is located on chromosome 16 and encodes a protein known as FAM182B, which is a key regulator of the cell cycle and has been shown to play a role in various cellular processes, including cell division, apoptosis, and inflammation.

Studies have suggested that changes in the levels of FAM182B have been associated with the development of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that high levels of FAM182B have been associated with an increased risk of developing breast cancer, and that reduced levels of FAM182B have been associated with an increased risk of developing Alzheimer's disease.

In addition to its potential as a drug target or biomarker, FAM182B is also of interest as a potential therapeutic target for other diseases. For example, FAM182B has been shown to play a role in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Furthermore, FAM182B has also been shown to be involved in inflammation, which is a major risk factor for many diseases, including cancer and neurodegenerative diseases. Therefore, FAM182B may be a promising target for anti-inflammatory therapies.

In conclusion, FAM182B is a gene that has potential as a drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of FAM182B in these diseases and to develop effective therapies that target this gene.

Protein Name: Family With Sequence Similarity 182 Member B

The "FAM182B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM182B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets